These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35750214)

  • 1. Reply to "Comment on Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy".
    Imanaga N; Koizumi H
    Am J Ophthalmol; 2022 Sep; 241():295. PubMed ID: 35750214
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy.
    Nishi O; Yasukawa T
    Am J Ophthalmol; 2022 Sep; 241():293-294. PubMed ID: 35750216
    [No Abstract]   [Full Text] [Related]  

  • 3. Loculation of Fluid in the Posterior Choroid in Eyes With Central Serous Chorioretinopathy.
    Spaide RF; Ryan EH
    Am J Ophthalmol; 2015 Dec; 160(6):1211-6. PubMed ID: 26299534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loculation of Fluid in the Posterior Choroid in Eyes With Central Serous Chorioretinopathy.
    Takkar B; Azad S; Sodhi PS
    Am J Ophthalmol; 2016 Mar; 163():194-195. PubMed ID: 26775252
    [No Abstract]   [Full Text] [Related]  

  • 5. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
    De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
    Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior choroidal fluid loculation in central serous chorioretinopathy presenting as a choroidal elevation: A rare Pachychoroid phenotype.
    Manayath GJ; Balan R; Ranjan R; Saravanan VR; Narendran V
    Eur J Ophthalmol; 2022 May; 32(3):1610-1618. PubMed ID: 34132140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of central serous chorioretinopathy: Expert panel discussion.
    Chhablani J; Anantharaman G; Behar-Cohen F; Boon C; Manayath G; Singh R
    Indian J Ophthalmol; 2018 Dec; 66(12):1700-1703. PubMed ID: 30451169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central serous chorioretinopathy mimicking as choroiditis.
    Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
    Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
    [No Abstract]   [Full Text] [Related]  

  • 9. Central Serous Chorioretinopathy.
    Daruich A; Matet A; Behar-Cohen F
    Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: Retinal pigment epithelial leak identification in central serous chorioretinopathy: Is fundus fluorescein angiography a must?
    Delhiwala K; Khamar B
    Indian J Ophthalmol; 2022 Mar; 70(3):895-896. PubMed ID: 35225538
    [No Abstract]   [Full Text] [Related]  

  • 11. Optical coherence tomography angiography in central serous chorioretinopathy: The current clinical role and future perspectives.
    Pujari A; Surve A; Azad SV; Beniwal A; Sj V; Chawla R; Sachan A; Kumar A; Kumar A
    Surv Ophthalmol; 2022; 67(1):68-82. PubMed ID: 34000252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on: Spectral domain optical coherence tomography predates fluorescein angiography in diagnosing central serous chorioretinopathy.
    Barange KK; Saha D
    Indian J Ophthalmol; 2010; 58(6):551-2; author reply 552. PubMed ID: 20952851
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography.
    Demirel S; Değirmenci MFK; Batıoğlu F; Özmert E
    Eur J Ophthalmol; 2021 Jan; 31(1):184-193. PubMed ID: 31684767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy.
    Imanaga N; Terao N; Sawaguchi S; Tamashiro T; Wakugawa S; Yamauchi Y; Koizumi H
    Am J Ophthalmol; 2022 Mar; 235():197-203. PubMed ID: 34547278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to Comment on OCT Risk Factors for 3-Year Development of Macular Complications in eyes with "Resolved" Chronic Central Serous Chorioretinopathy.
    Borrelli E; Sacconi R; Battista M; Bandello F; Querques G
    Am J Ophthalmol; 2021 Sep; 229():314-317. PubMed ID: 33857505
    [No Abstract]   [Full Text] [Related]  

  • 16. Masqueraders of central serous chorioretinopathy.
    Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
    Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy.
    Marchese A; Miserocchi E; Modorati G; Querques G; Bandello F
    Retina; 2018 Jul; 38(7):e53-e54. PubMed ID: 29697592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.